The relative influences of symptoms, insight, and neurocognition on social adjustment in schizophrenia and schizoaffective disorder

被引:169
作者
Smith, TE
Hull, JW
Goodman, M
Hedayat-Harris, A
Willson, DF
Israel, LM
Munich, RL
机构
[1] Cornell Univ, New York Presbyterian Hosp, Dept Psychiat,Weill Med Coll, Westchester Div, White Plains, NY 10605 USA
[2] Family Serv Westchester, White Plains, NY USA
[3] Four Winds Hosp, Katonah, NY USA
[4] Menninger Clin, Topeka, KS USA
[5] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
关键词
D O I
10.1097/00005053-199902000-00006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Impaired insight and neurocognitive deficits are commonly seen in schizophrenia. No study to date, however, has documented the relative influences of insight deficits, neurocognitive functioning, and psychotic symptoms on overall social adjustment in this population. This was done in a cohort; of individuals recovering from acute exacerbations. Forty-six individuals with schizophrenia or schizoaffective disorder were recruited upon discharge from an inpatient unit. Symptom levels, neurocognitive functioning (information processing, memory, and executive functioning), and symptom awareness were documented, and social adjustment was assessed in three domains: treatment compliance, social behavior, and subjective quality of life. Cross-sectional data from initial assessments are reported. Sequential linear regression analyses identified differential associations between illness characteristics and outcome domains. Treatment compliance was most influenced by insight; social behavior deficits were associated with thought disorder and neurocognitive (working memory and visuo-spatial) impairments; and quality of life was associated with mood disturbances. Outcome is multidimensional in schizophrenia, and there are differential patterns of associations between illness characteristics and domains of social adjustment. Studies such, as this can guide clinicians in determining the most appropriate treatments for specific individuals and should also guide researchers in efforts to clarify the processes that underlie treatment response and recovery in schizophrenia.
引用
收藏
页码:102 / 108
页数:7
相关论文
共 47 条
[1]  
AMADOR XF, 1993, AM J PSYCHIAT, V150, P873
[2]  
AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826
[3]  
Andreasen N, 1984, SCALE ASSESSMENT NEG
[4]  
Andreasen N.C., 1983, SCALE ASSESSMENT POS
[5]  
ANDREASEN NC, 1995, ARCH GEN PSYCHIAT, V52, P341
[6]  
ANTHONY WA, 1995, PSYCHIATR SERV, V46, P353
[7]  
ANTHONY WA, 1984, CHRONIC MENTAL PATIE, P213
[8]  
ASARNOW R, 1991, HDB SCHIZOPHRENIA, V5, P335
[9]  
Atkinson M, 1997, AM J PSYCHIAT, V154, P99
[10]   CLINICAL SYMPTOMATOLOGY AND DRUG COMPLIANCE IN SCHIZOPHRENIC-PATIENTS [J].
BARTKO, G ;
HERCZEG, I ;
ZADOR, G .
ACTA PSYCHIATRICA SCANDINAVICA, 1988, 77 (01) :74-76